STERIS Plc Hits New 52-Week Low at USD 195.14

STERIS Plc (Ireland), a mid-cap player in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low of USD 195.14 on May 7, 2026. This decline marks a significant shift in the stock's performance, as it has recorded a 1-year performance of -4.93%, contrasting sharply with the S&P 500's impressive gain of 30.29% during the same period. The company's market capitalization stands at USD 21,483 million, reflecting its mid-sized status within the industry. STERIS has a price-to-earnings (P/E) ratio of 28.00, indicating how the market values its earnings relative to its share price. Additionally, the stock offers a dividend yield of 1.12%, which may appeal to income-focused investors. With a debt-to-equity ratio of 0.21 and a return on equity of 10.82%, STERIS demonstrates a relatively low level of debt and a solid return on its equity investments. The stock's 52-week high was recorded at USD 269.23, highlighting the volatility and fluctuations in its market performance over the past year.